Wird geladen...

Golimumab for the treatment of ulcerative colitis

The introduction of therapeutic antibodies against tumor necrosis factor (TNF) had a major impact on the treatment of ulcerative colitis (UC). Infliximab and adalimumab are powerful agents that are used for remission induction and maintenance therapy in UC and have an acceptable safety profile. Howe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Löwenberg, Mark, de Boer, Nanne KH, Hoentjen, Frank
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2014
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3958527/
https://ncbi.nlm.nih.gov/pubmed/24648749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S48741
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!